1 study found for:    15136498 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase 2, Investigator-Initiated, Feasibility Study to Evaluate the Mechanisms of Coronary Endothelial Dysfunction Imaged As Resting Myocardial Perfusion Heterogeneity After Endothelin Receptor Blockade With Darusentan
Conditions: Coronary Artery Disease;   Endothelial Dysfunction;   Myocardial Perfusion Defect
Intervention: Drug: darusentan 100 mg

Indicates status has not been verified in more than two years